UniProt ID | TGFR2_HUMAN | |
---|---|---|
UniProt AC | P37173 | |
Protein Name | TGF-beta receptor type-2 | |
Gene Name | TGFBR2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 567 | |
Subcellular Localization |
Cell membrane Single-pass type I membrane protein . Membrane raft . |
|
Protein Description | Transmembrane serine/threonine kinase forming with the TGF-beta type I serine/threonine kinase receptor, TGFBR1, the non-promiscuous receptor for the TGF-beta cytokines TGFB1, TGFB2 and TGFB3. Transduces the TGFB1, TGFB2 and TGFB3 signal from the cell surface to the cytoplasm and is thus regulating a plethora of physiological and pathological processes including cell cycle arrest in epithelial and hematopoietic cells, control of mesenchymal cell proliferation and differentiation, wound healing, extracellular matrix production, immunosuppression and carcinogenesis. The formation of the receptor complex composed of 2 TGFBR1 and 2 TGFBR2 molecules symmetrically bound to the cytokine dimer results in the phosphorylation and the activation of TGFRB1 by the constitutively active TGFBR2. Activated TGFBR1 phosphorylates SMAD2 which dissociates from the receptor and interacts with SMAD4. The SMAD2-SMAD4 complex is subsequently translocated to the nucleus where it modulates the transcription of the TGF-beta-regulated genes. This constitutes the canonical SMAD-dependent TGF-beta signaling cascade. Also involved in non-canonical, SMAD-independent TGF-beta signaling pathways.. | |
Protein Sequence | MGRGLLRGLWPLHIVLWTRIASTIPPHVQKSVNNDMIVTDNNGAVKFPQLCKFCDVRFSTCDNQKSCMSNCSITSICEKPQEVCVAVWRKNDENITLETVCHDPKLPYHDFILEDAASPKCIMKEKKKPGETFFMCSCSSDECNDNIIFSEEYNTSNPDLLLVIFQVTGISLLPPLGVAISVIIIFYCYRVNRQQKLSSTWETGKTRKLMEFSEHCAIILEDDRSDISSTCANNINHNTELLPIELDTLVGKGRFAEVYKAKLKQNTSEQFETVAVKIFPYEEYASWKTEKDIFSDINLKHENILQFLTAEERKTELGKQYWLITAFHAKGNLQEYLTRHVISWEDLRKLGSSLARGIAHLHSDHTPCGRPKMPIVHRDLKSSNILVKNDLTCCLCDFGLSLRLDPTLSVDDLANSGQVGTARYMAPEVLESRMNLENVESFKQTDVYSMALVLWEMTSRCNAVGEVKDYEPPFGSKVREHPCVESMKDNVLRDRGRPEIPSFWLNHQGIQMVCETLTECWDHDPEARLTAQCVAERFSELEHLDRLSGRSCSEEKIPEDGSLNTTK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
31 | O-linked_Glycosylation | IPPHVQKSVNNDMIV CCHHHHHHCCCCEEE | 17.00 | OGP | |
31 (in isoform 2) | Phosphorylation | - | 17.00 | - | |
39 | O-linked_Glycosylation | VNNDMIVTDNNGAVK CCCCEEEECCCCCCC | 23.29 | 55833639 | |
64 (in isoform 2) | O-linked_Glycosylation | - | 26.28 | OGP | |
70 | N-linked_Glycosylation | NQKSCMSNCSITSIC CCHHHHCCCEEEHHC | 9.18 | UniProtKB CARBOHYD | |
94 | N-linked_Glycosylation | VWRKNDENITLETVC EEEECCCCEEEEEEE | 35.09 | UniProtKB CARBOHYD | |
118 | Phosphorylation | FILEDAASPKCIMKE HHCCCCCCCCCEECC | 26.98 | 26091039 | |
154 | N-linked_Glycosylation | IIFSEEYNTSNPDLL EEEECCCCCCCCCEE | 40.07 | UniProtKB CARBOHYD | |
205 | Ubiquitination | SSTWETGKTRKLMEF HHHHCCCCHHHHHHH | 53.21 | - | |
208 | Ubiquitination | WETGKTRKLMEFSEH HCCCCHHHHHHHHHH | 58.37 | - | |
213 | Phosphorylation | TRKLMEFSEHCAIIL HHHHHHHHHHEEEEE | 17.08 | 9155023 | |
225 | Phosphorylation | IILEDDRSDISSTCA EEECCCCCHHHHHHC | 46.41 | 8947046 | |
228 | Phosphorylation | EDDRSDISSTCANNI CCCCCHHHHHHCCCC | 25.28 | 8947046 | |
229 | Phosphorylation | DDRSDISSTCANNIN CCCCHHHHHHCCCCC | 28.04 | 8947046 | |
259 | Phosphorylation | KGRFAEVYKAKLKQN CCCHHHHHHHHHHCC | 9.20 | 9169454 | |
260 | Ubiquitination | GRFAEVYKAKLKQNT CCHHHHHHHHHHCCC | 44.19 | - | |
264 | Ubiquitination | EVYKAKLKQNTSEQF HHHHHHHHCCCCHHH | 40.57 | - | |
268 | Phosphorylation | AKLKQNTSEQFETVA HHHHCCCCHHHCEEE | 36.63 | 23403867 | |
284 | Phosphorylation | KIFPYEEYASWKTEK EEECHHHHCCCCCHH | 8.26 | 9169454 | |
286 | Phosphorylation | FPYEEYASWKTEKDI ECHHHHCCCCCHHHH | 28.36 | 24719451 | |
291 | Ubiquitination | YASWKTEKDIFSDIN HCCCCCHHHHHHCCC | 62.45 | - | |
295 | Phosphorylation | KTEKDIFSDINLKHE CCHHHHHHCCCCCHH | 37.60 | 28102081 | |
300 | Ubiquitination | IFSDINLKHENILQF HHHCCCCCHHHHHHH | 44.37 | - | |
336 | Phosphorylation | AKGNLQEYLTRHVIS CCCCHHHHHHHHCCC | 10.62 | 9169454 | |
352 | Phosphorylation | EDLRKLGSSLARGIA HHHHHHHHHHHHHHH | 32.39 | 23927012 | |
353 | Phosphorylation | DLRKLGSSLARGIAH HHHHHHHHHHHHHHH | 25.01 | 23927012 | |
381 | Ubiquitination | PIVHRDLKSSNILVK CEEECCCCCCCEEEE | 57.01 | - | |
383 | Phosphorylation | VHRDLKSSNILVKND EECCCCCCCEEEECC | 26.71 | 22210691 | |
392 | Phosphorylation | ILVKNDLTCCLCDFG EEEECCEEEEECCCC | 12.20 | 22210691 | |
409 | Phosphorylation | LRLDPTLSVDDLANS EECCCCCCHHHHHHC | 26.44 | 26657352 | |
416 | Phosphorylation | SVDDLANSGQVGTAR CHHHHHHCCCCCCHH | 25.62 | 9169454 | |
424 | Phosphorylation | GQVGTARYMAPEVLE CCCCCHHHCCHHHHH | 8.65 | 28152594 | |
441 | Phosphorylation | MNLENVESFKQTDVY CCCCCHHHHHHCCHH | 33.20 | 9169454 | |
445 | Phosphorylation | NVESFKQTDVYSMAL CHHHHHHCCHHHHHH | 28.20 | - | |
448 | Phosphorylation | SFKQTDVYSMALVLW HHHHCCHHHHHHHHH | 8.78 | 26074081 | |
449 | Phosphorylation | FKQTDVYSMALVLWE HHHCCHHHHHHHHHH | 9.45 | 26074081 | |
470 | Phosphorylation | AVGEVKDYEPPFGSK CCEECCCCCCCCCCC | 25.31 | 30576142 | |
476 | Phosphorylation | DYEPPFGSKVREHPC CCCCCCCCCCCCCCC | 28.49 | 30576142 | |
477 | Ubiquitination | YEPPFGSKVREHPCV CCCCCCCCCCCCCCH | 45.77 | - | |
486 | Phosphorylation | REHPCVESMKDNVLR CCCCCHHHHHHHCHH | 15.67 | 23403867 | |
488 | Ubiquitination | HPCVESMKDNVLRDR CCCHHHHHHHCHHCC | 56.27 | - | |
539 | Phosphorylation | QCVAERFSELEHLDR HHHHHHHHHHHHHHH | 47.71 | 23403867 | |
548 | Phosphorylation | LEHLDRLSGRSCSEE HHHHHHHCCCCCCCC | 32.81 | 30266825 | |
551 | Phosphorylation | LDRLSGRSCSEEKIP HHHHCCCCCCCCCCC | 26.06 | 8947046 | |
553 | Phosphorylation | RLSGRSCSEEKIPED HHCCCCCCCCCCCCC | 50.46 | 23401153 | |
556 | Neddylation | GRSCSEEKIPEDGSL CCCCCCCCCCCCCCC | 60.55 | - | |
556 | Ubiquitination | GRSCSEEKIPEDGSL CCCCCCCCCCCCCCC | 60.55 | - | |
562 | Phosphorylation | EKIPEDGSLNTTK-- CCCCCCCCCCCCC-- | 30.67 | 23403867 | |
565 | Phosphorylation | PEDGSLNTTK----- CCCCCCCCCC----- | 41.05 | 23403867 | |
566 | Phosphorylation | EDGSLNTTK------ CCCCCCCCC------ | 33.41 | 25159151 | |
567 | Neddylation | DGSLNTTK------- CCCCCCCC------- | 57.19 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
213 | S | Phosphorylation | Kinase | TGFR2 | P37173 | PhosphoELM |
259 | Y | Phosphorylation | Kinase | TGFR2 | P37173 | PhosphoELM |
284 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
284 | Y | Phosphorylation | Kinase | SRC | P05480 | PSP |
336 | Y | Phosphorylation | Kinase | TGFR2 | P37173 | PhosphoELM |
409 | S | Phosphorylation | Kinase | TGFR2 | P37173 | PhosphoELM |
416 | S | Phosphorylation | Kinase | TGFR2 | P37173 | PhosphoELM |
424 | Y | Phosphorylation | Kinase | TGFR2 | P37173 | PhosphoELM |
- | K | Ubiquitination | E3 ubiquitin ligase | NEDD4L | Q96PU5 | PMID:15817471 |
- | K | Ubiquitination | E3 ubiquitin ligase | WWP1 | Q9H0M0 | PMID:15817471 |
- | K | Ubiquitination | E3 ubiquitin ligase | SMURF1 | Q9HCE7 | PMID:15817471 |
- | K | Ubiquitination | E3 ubiquitin ligase | SMURF2 | Q9HAU4 | PMID:22848678 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TGFR2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TGFR2_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
H00020 | Colorectal cancer | |||||
H00800 | Loeys-Dietz syndrome (LDS) | |||||
H00801 | Familial thoracic aortic aneurysm and dissection (TAAD); Aortic aneurysm familial thoracic type (AAT | |||||
OMIM Disease | ||||||
614331 | Hereditary non-polyposis colorectal cancer 6 (HNPCC6) | |||||
133239 | Esophageal cancer (ESCR) | |||||
610168 | Loeys-Dietz syndrome 2 (LDS2) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-409; SER-548; SER-551AND SER-553, AND MASS SPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-548, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-548, AND MASSSPECTROMETRY. |